Scholarly Index
John M. McLaughlin
Pfizer (United States); 7,024 total citations; 135 total publications; best world rank #39
Pfizer (United States)
7,024Total citations
135Total publications
36H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| SARS-CoV-2 and COVID-19 Research | Lifetime | 729 | US 249 | 97.69 |
| COVID-19 Clinical Research Studies | Lifetime | 883 | US 202 | 97.06 |
| Vaccine Coverage and Hesitancy | Lifetime | 410 | US 200 | 97.21 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 39 | US 19 | 98.93 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 152 | US 59 | 99.28 |
| COVID-19 Clinical Research Studies | 2021-2025 | 207 | US 61 | 98.92 |
| COVID-19 epidemiological studies | 2021-2025 | 668 | US 139 | 92.53 |
| Respiratory viral infections research | 2021-2025 | 532 | US 202 | 92.36 |